Jubilant Life zooms 10% as firm gets USFDA nod for drug
Jubilant Life Sciences shares soared almost 10 per cent, to touch its 52-week high level today, as the company received final approval from the US health regulator for its generic version of anti-depressant Paxil tablets.
Dec 01, 2015, 15:02 PM IST
Jubilant to market Technegas in US, signs pact with Cyclopharm
Technegas is an imaging agent primarily used in Pulmonary Embolism (blockage of lung arteries).
Sep 14, 2015, 13:21 PM IST
Jubilant Life shares gain over 2% at close
Trimming most of its initial gains on profit-booking, shares of Jubilant Life Sciences ended over 2 percent higher on Wednesday.
Jun 17, 2015, 17:39 PM IST
Aurobindo, Lupin & Jubilant get USFDA nod for hypertension drug
Three domestic firms, Aurobindo Pharma, Lupin and Jubilant Life Sciences, have received final approval from US health regulator to sell generic copies of Valsartan tablets used for treatment of hypertension.
Jan 06, 2015, 19:47 PM IST
Jubilant acquires all outstanding shares of Cadista Holdings
Jubilant Life Sciences has completed tender offer to acquire all outstanding shares of Cadista Holdings Inc, thereby making the US-based firm as its wholly-owned subsidiary.
Dec 23, 2014, 14:42 PM IST
